Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma
- DOI
- 10.1158/1078-0432.ccr-19-3538
- Published
- 2020-07-01
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-19-3538,
title = {Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma},
author = {Michaël H. Meel and Mark C. de Gooijer and Dennis S. Metselaar and A. Charlotte P. Sewing and Kenn Zwaan and Piotr Waranecki and Marjolein Breur and Levi C.M. Buil and Tonny Lagerweij and Laurine E. Wedekind and Jos W.R. Twisk and Jan Koster and Rintaro Hashizume and Eric H. Raabe and Ángel Montero Carcaboso and Marianna Bugiani and Timothy N. Phoenix and Olaf van Tellingen and Dannis G. van Vuurden and Gertjan J.L. Kaspers and Esther Hulleman},
year = {2020},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-19-3538},
url = {https://doi.org/10.1158/1078-0432.ccr-19-3538}
}RIS
TY - JOUR TI - Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma AU - Michaël H. Meel AU - Mark C. de Gooijer AU - Dennis S. Metselaar AU - A. Charlotte P. Sewing AU - Kenn Zwaan AU - Piotr Waranecki AU - Marjolein Breur AU - Levi C.M. Buil AU - Tonny Lagerweij AU - Laurine E. Wedekind AU - Jos W.R. Twisk AU - Jan Koster AU - Rintaro Hashizume AU - Eric H. Raabe AU - Ángel Montero Carcaboso AU - Marianna Bugiani AU - Timothy N. Phoenix AU - Olaf van Tellingen AU - Dannis G. van Vuurden AU - Gertjan J.L. Kaspers AU - Esther Hulleman PY - 2020 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-19-3538 UR - https://doi.org/10.1158/1078-0432.ccr-19-3538 ER -
APA
Meel, M. H., Gooijer, M. C. D., Metselaar, D. S., Sewing, A. C. P., Zwaan, K., Waranecki, P., Breur, M., Buil, L. C., Lagerweij, T., Wedekind, L. E., Twisk, J. W., Koster, J., Hashizume, R., Raabe, E. H., Carcaboso, Á. M., Bugiani, M., Phoenix, T. N., Tellingen, O. V., Vuurden, D. G. V., Kaspers, G. J., & Hulleman, E. (2020). Combined Therapy of AXL and HDAC Inhibition Reverses Mesenchymal Transition in Diffuse Intrinsic Pontine Glioma. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-19-3538
Source records
- crossref · retrieved 2026-09-26T14:18:35.590Z